Pharmaceuticals removal from hospital wastewater by fluidized aerobic bioreactor in combination with tubesettler

Micropollutants, especially pharmaceutical compounds, are of significant concern owing to their ngL(- 1) to mu gL(- 1) concentration, making them difficult for conventional treatment plants to remove from wastewater. Despite municipal wastewater treatment plant being a primary source of these compounds to be released into the wastewater, on comparison little attention has been given to hospital wastewater. The major focus of studies addressing pharmaceutical compounds is based on synthetic wastewater. This study addresses this research gap by treating wastewater to remove micropollutants (Fluvastatin, ketoprofen, paracetamol, ciprofloxacin, carbamazepine, sulfamethoxazole, and lorazepam) by employing a fluidized aerobic bioreactor. Tubesettler was attached to a fluidized-bed bioreactor to see if it could be used as a polishing unit rather than a secondary clarifier. The environmental risk from the effluent discharge into the environment was assessed regarding the hazard quotient. The paracetamol and ketoprofen were removed at an efficiency of 51% and 60%, respectively, followed by carbamazepine at 50%, ciprofloxacin at 40%, fluvastatin at 47%, sulfamethoxazole at 31%, and lorazepam at 20%. The influent posed moderate environmental risk with (Hazard Quotient) HQ > 0.5, while in effluent the risk was reduced with HQ value 0.4. For effluent from fluidized bed bioreactors (HQ 0.13) and tube setters (HQ 0.15). The associated tube settler was found suitable for polishing units with additional removal efficiencies of 15-43% for all the targeted pharmaceutical compounds. Further studies are required to explore disinfectants' effect on the reactor's biodegradation efficiency. Also, further modification and a hybrid version of the fluidized bed bioreactor can be used.